Product Detail

Product Description Rifadin (rifampin) capsules, USP, 150 mg, 100-count capsules per bottle, Manufactured by: Fabrique par Sanofi-Aventis Canada Inc., Laval, Quebec, Canada H7L4A8, DIN # 02091887

Recall Number D-886-2013

Classification Class II

Code Info Lot # 3099036, Exp 03/2014

Product Distributed Qty 998 Bottles

Reason For Recall Subpotent Drug: During review of retain samples, the manufacturer observed low fill in some capsules, which was related to an issue detected with the encapsulating equipment.

Event Detail

Event Id 65954

Product Type Drugs

Status Ongoing

Recalling Firm
Sanofi-Synthelabo
City Laval

State
Country CA

Voluntary / Mandated Voluntary: Firm Initiated

Recall Initiation Date 2013-02-26

Initial Firm Notification of Consignee or Public Letter

Distribution Pattern Canada